Hornik, Ezra S.
Altman-Merino, Anne E.
Koefoed, Andrew W.
Meyer, Kayla M.
Stone, Isabella B.
Green, Jessica A.
Williams, Gordon H.
Adler, Gail K.
Williams, Jonathan S.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL136567)
National Center for Advancing Translational Sciences (UL1TR002541)
Article History
Received: 17 June 2020
Accepted: 7 July 2020
First Online: 14 July 2020
Ethics approval and consent to participate
: This protocol was approved by the Partners Human Research Committee, which is the Institutional Review Board for Partners/Mass General Brigham. The Partners Human Research Committee will review and approve all protocol amendments, adverse events, and protocol deviations. A Data and Safety Monitoring Plan will include physician-investigators and lay representatives from the Cardiovascular Endocrinology Research Group who will review protocol deviations and adverse events monthly to ensure the integrity of the protocol and safety of participants. All participants will give written informed consent to participate, which will be obtained by a physician approved by the IRB to contribute to this protocol.
: Not applicable. The manuscript does not contain data from any individual person.
: The authors declare that they have no competing interests.